| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |